))
The Future of Psychedelic Psychotherapy
Manage episode 285216592 series 2828920
Content provided by Piers Kaniuka. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Piers Kaniuka or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In Episode 14 Piers and psychedelic researcher and activist Brett Greene discuss the future of psychedelic psychotherapy. Recorded on February 6, 2021.
Brett Greene is Chief Innovation Officer of Cybin, a leading biotechnology company focused on psychedelic therapeutics. Brett was co-founder of Psymposia a non-profit media organization that offers perspectives on drugs, politics, and culture. He also was the founder of Adelia Therapeutics a biopharmaceutical company dedicated to developing psychedelic therapeutics. You can find him on LinkedIn.
Resistance Recovery (RR) is reimagining addiction, recovery, and community in the 21st century. Piers Kaniuka, MTS, MS has worked with thousands of addicts and alcoholics in his 25+ years in the field. Discover RR's new paradigm of addiction recovery by visiting Resistance Recovery.
Visit the RR YouTube channel: https://www.youtube.com/c/RESISTANCERECOVERY
Sign-up for Long Threads and get Resistance Recovery news: https://mailchi.mp/ddc8023bec67/welcometoresistancerecovery
Support this podcast at — https://redcircle.com/resistance-recovery/donations
58 episodes
Share
